UBS O'Connor’s COVA Acquisition Corp. Warrants to purchase Class A ordinary shares COVAW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-209,405
Closed -$37K 1068
2022
Q1
$37K Buy
209,405
+3,701
+2% +$1.24K ﹤0.01% 914
2021
Q4
$102K Buy
205,704
+5,515
+3% +$3.23K ﹤0.01% 836
2021
Q3
$110K Hold
200,189
﹤0.01% 815
2021
Q2
$183K Buy
+200,189
New +$139K ﹤0.01% 741

Other funds holding COVAW

UBS O'Connor's COVAW Position: Q2 2022 in Review

UBS O'Connor sold out of COVA Acquisition Corp. Warrants to purchase Class A ordinary shares (COVAW) in Q2 2022, closing a stake of 209,405 shares — an estimated $37K sold.

UBS O'Connor first reported a position in COVAW in Q2 2021 and held it in 4 quarters. The position peaked at $183K in Q2 2021. 65 funds tracked by Wall St. Rank hold COVAW as of Q2 2022.

  • UBS O'Connor reported no remaining COVA Acquisition Corp. Warrants to purchase Class A ordinary shares position as of Q2 2022 after selling out during the quarter.
  • UBS O'Connor sold 209,405 COVA Acquisition Corp. Warrants to purchase Class A ordinary shares shares in Q2 2022, an estimated $37K.
  • UBS O'Connor first reported a position in COVA Acquisition Corp. Warrants to purchase Class A ordinary shares in Q2 2021 and held it in 4 quarters.
  • UBS O'Connor's COVA Acquisition Corp. Warrants to purchase Class A ordinary shares position peaked at $183K in Q2 2021.
  • 65 funds tracked by Wall St. Rank held COVA Acquisition Corp. Warrants to purchase Class A ordinary shares as of Q2 2022.

Based on UBS O'Connor's 13F filing for Q2 2022, filed 12 Aug 2022.